Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Through the BioInnovation Institute Science Prize for Innovation, the editors of Science seek to recognize bold researchers who are asking fundamental questions at the intersection of the life sciences and entrepreneurship...

We are pleased to open the call for applications for the CBS Mentorship and Professional Development, a program specifically designed to connect professionals outside of academia with graduate students and postdoctoral fellows coming from the Canadian biomaterial s community...

14th Intl Symposium on Biodegradable Metals for Applications on behalf of Professor Mantovani and the Quebec City Student Chapter Want to discover the next generation of bioresorbable metals aiming to bridge the gap between biomaterials and tissue engineering for pediatric, dental, orthopedic, vascular, cardiac, neurological applications, and more? The final program of the upcoming 14th Intl Symposium on Biodegradable Metals for Biomedical Applications is now online...

Dear CBS members on behalf of the OBIO WiHI Program , The OBIO Women in the Business of Health Science Bootcamp will take place between September 12 16, 2022, and is available at no cost to eligible applicants...

Despite a rocky start, DNA-based gene therapy is re-gaining footing with the development of cutting-edge biodegradable materials...

The thromboembolic disease is currently one of the most hazardous and mortal diseases to human beings...

3D printable bio-based nanocomposites are a promising material for biomedical applications, such as in dentistry, skeletal reconstruction, and sustainable rapid prototyping 1 2 ...

In the area of cancer research, a major issue with conventional 2D cell culture is that it cannot reproduce complex in vivo cell-extracellular matrix ECM interactions, nor those between cancer epithelial cells and stromal compartment, which play a crucial role in tumorigenesis and progression...

Genetically tailored human mesenchymal stem cells MSC are studied extensively to develop cell-based therapies for bone defects...